SPESP1 and skin neoplasm: Next, we employed a commercial tissue microarray (TMA) covering 84 benign and malign skin tumors, 12 samples from other tumors (breast, ear, fibrous tissue, parotid gland, vulva), and four normal skin samples to analyze SPESP1's staining pattern (SK803a) (Fig. S5A).